130 related articles for article (PubMed ID: 35671592)
1. Estrogen receptor β-targeted hypoxia-responsive near-infrared fluorescence probes for prostate cancer study.
Xie B; Meng Q; Yu H; Shen K; Cheng Y; Dong C; Zhou HB
Eur J Med Chem; 2022 Aug; 238():114506. PubMed ID: 35671592
[TBL] [Abstract][Full Text] [Related]
2. Development of Highly Efficient Estrogen Receptor β-Targeted Near-Infrared Fluorescence Probes Triggered by Endogenous Hydrogen Peroxide for Diagnostic Imaging of Prostate Cancer.
He P; Deng X; Xu B; Xie B; Zou W; Zhou H; Dong C
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903555
[TBL] [Abstract][Full Text] [Related]
3. Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer.
He P; Yu H; Deng X; Xin L; Xu B; Zhou HB; Dong C
Eur J Med Chem; 2024 Mar; 268():116236. PubMed ID: 38367494
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor β-Targeted Near-Infrared Inherently Fluorescent Probe: A Potent Tool for Estrogen Receptor β Research.
Meng Q; Xie B; Yu H; Shen K; Deng X; Zhou HB; Dong C
ACS Sens; 2022 Jan; 7(1):109-115. PubMed ID: 34914372
[TBL] [Abstract][Full Text] [Related]
5. A high-affinity subtype-selective fluorescent probe for estrogen receptor β imaging in living cells.
Hu Z; Yang L; Ning W; Tang C; Meng Q; Zheng J; Dong C; Zhou HB
Chem Commun (Camb); 2018 Apr; 54(31):3887-3890. PubMed ID: 29610818
[TBL] [Abstract][Full Text] [Related]
6. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment pH-responsive pentagonal gold prism-based nanoplatform for multimodal imaging and combined therapy of castration-resistant prostate cancer.
Tan H; Liu Y; Hou N; Cui S; Liu B; Fan S; Yu G; Han C; Zheng D; Li W; Liu Y; Xu B; Wang Z; Cui D
Acta Biomater; 2022 Mar; 141():408-417. PubMed ID: 35032718
[TBL] [Abstract][Full Text] [Related]
8. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts.
Lip H; Amini MA; Zetrini A; Cai P; Abbasi AZ; Bristow RG; Rauth AM; Wu XY
Radiother Oncol; 2022 May; 170():213-223. PubMed ID: 35227733
[TBL] [Abstract][Full Text] [Related]
9. Robust ERα-Targeted Near-Infrared Fluorescence Probe for Selective Hydrazine Imaging in Breast Cancer.
Tang C; Tong H; Liu B; Wang X; Jin Y; Tian E; Wang F
Anal Chem; 2022 Oct; 94(40):14012-14020. PubMed ID: 36166661
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
[TBL] [Abstract][Full Text] [Related]
11. ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1.
Mak P; Li J; Samanta S; Mercurio AM
Oncotarget; 2015 Nov; 6(37):40247-54. PubMed ID: 26450901
[TBL] [Abstract][Full Text] [Related]
12. Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative.
Su Q; Wu Q; Chen K; Wang J; Sarwar A; Zhang Y
Mol Biol Rep; 2022 Feb; 49(2):1223-1232. PubMed ID: 34792729
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging.
Ai S; Dong W; Li J; Yang Z
J Biomed Nanotechnol; 2022 Apr; 18(4):1019-1027. PubMed ID: 35854443
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria targeted near-infrared chemodosimeter for upconversion luminescence bioimaging of hypoxia.
Yu H; Sun W; Tiemuer A; Zhang Y; Wang HY; Liu Y
Chem Commun (Camb); 2021 May; 57(42):5207-5210. PubMed ID: 33908481
[TBL] [Abstract][Full Text] [Related]
15. Probing the prostate tumour microenvironment II: Impact of hypoxia on a cell model of prostate cancer progression.
Tonry C; Armstrong J; Pennington S
Oncotarget; 2017 Feb; 8(9):15307-15337. PubMed ID: 28410543
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging.
Li Y; Sun Y; Li J; Su Q; Yuan W; Dai Y; Han C; Wang Q; Feng W; Li F
J Am Chem Soc; 2015 May; 137(19):6407-16. PubMed ID: 25923361
[TBL] [Abstract][Full Text] [Related]
17. Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β.
Tao X; Xu L; Yin L; Han X; Qi Y; Xu Y; Song S; Zhao Y; Peng J
Cell Death Dis; 2017 Aug; 8(8):e2989. PubMed ID: 28796245
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator.
Lim W; Park Y; Cho J; Park C; Park J; Park YK; Park H; Lee Y
Breast Cancer Res; 2011 Mar; 13(2):R32. PubMed ID: 21435239
[TBL] [Abstract][Full Text] [Related]
19. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-sensitive fluorescent probes for in vivo real-time fluorescence imaging of acute ischemia.
Kiyose K; Hanaoka K; Oushiki D; Nakamura T; Kajimura M; Suematsu M; Nishimatsu H; Yamane T; Terai T; Hirata Y; Nagano T
J Am Chem Soc; 2010 Nov; 132(45):15846-8. PubMed ID: 20979363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
